Pil-Soo Sung

57PUBLICATIONS
100CO-AUTHORS
Medical infection agents (incl. prions)AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (57)

|Sep 27, 2026
PNPLA3 Is Associated With Hepatocellular Carcinoma, While a Five-Variant Polygenic Risk Score Shows Limited Discrimination in Korean Patients With MASLD.

|Sep 07, 2026
Blocking the gut-liver IgA axis attenuates macrophage-mediated inflammation and injury in alcohol-associated liver disease.

|Sep 01, 2026
Regorafenib as Second-Line Versus Later-Line Therapy in Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study with Exploratory Analysis of Prior Immune Checkpoint Inhibitor Exposure.

|Aug 04, 2026
Comparison of Second-line Hepatic Arterial Infusion Chemotherapy and Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma.

|Feb 27, 2026
Shelterin Component TPP1 Drives Tumor Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma.

Jung Eun Jang, Hye Seon Kim, Jin Seoub Kim

|Jan 14, 2026
Challenges of an EMR-Based Hospital Alert Program for Micro-Elimination of Hepatitis C in Tertiary Referral Hospitals.

Hee Yeon Kim, Hae Lim Lee, Heechul Nam

Pageof 10

Frequent Collaborators

27 joint publications

Jeong-Won Jang

26 joint publications

Seung-Kew Yoon

24 joint publications

Ji-Won Han

19 joint publications

Si-Hyun Bae